BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 21173650)

  • 1. Clearance of human papillomavirus in women treated for cervical dysplasia.
    Moore EE; Danielewski JA; Garland SM; Tan J; Quinn MA; Stevens MP; Tabrizi SN
    Obstet Gynecol; 2011 Jan; 117(1):101-108. PubMed ID: 21173650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-risk human papillomavirus cervical infections among healthy women in Guadeloupe.
    Cordel N; Ragin C; Trival M; Tressières B; Janky E
    Int J Infect Dis; 2015 Dec; 41():13-6. PubMed ID: 26597118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
    Melinte-Popescu A; Costăchescu G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of high risk human papillomavirus infection with different cervical cytological features among women undergoing health examination at the National Cancer Institute, Thailand.
    Laowahutanont P; Karalak A; Wongsena M; Loonprom K; Pukcharoen P; Jamsri P; Sangrajrang S
    Asian Pac J Cancer Prev; 2014; 15(14):5879-82. PubMed ID: 25081717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV-related cervical disease and oropharyngeal cancer.
    Lozza V; Pieralli A; Corioni S; Longinotti M; Bianchi C; Moncini D; Fallani MG
    Arch Gynecol Obstet; 2014 Aug; 290(2):375-9. PubMed ID: 24584479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types.
    McKenzie ND; Kobetz EN; Hnatyszyn J; Twiggs LB; Lucci JA
    Gynecol Oncol; 2010 Mar; 116(3):572-7. PubMed ID: 19906410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triage of women with negative cytology and positive high-risk HPV: an analysis of data from the SHENCCAST II/III studies.
    Goodrich SK; Pretorius RG; Du H; Wu R; Belinson JL
    J Low Genit Tract Dis; 2014 Apr; 18(2):122-7. PubMed ID: 24270196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.
    Monsonego J; Zerat L; Syrjänen K; Zerat JC; Smith JS; Halfon P
    Vaccine; 2012 Jul; 30(35):5215-21. PubMed ID: 22713720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings.
    Tezcan S; Ozgur D; Ulger M; Aslan G; Gurses I; Serin MS; Giray BG; Dilek S; Emekdas G
    Asian Pac J Cancer Prev; 2014; 15(9):3997-4003. PubMed ID: 24935586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cervical cancer in women with ASCUS in the Brazilian Unified National Health System: cost-effectiveness of the molecular biology method for HPV detection.
    Nomelini RS; Guimarães PD; Candido PA; Campos AC; Michelin MA; Murta EF
    Cad Saude Publica; 2012 Nov; 28(11):2043-52. PubMed ID: 23147946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
    Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between the evidence of human papilloma virus infection in bladder transitional cell carcinoma in men and cervical dysplasia in their spouses.
    Barghi MR; Rahjoo T; Borghei M; Hosseini-Moghaddam SM; Amani D; Farrokhi B
    Arch Iran Med; 2012 Sep; 15(9):572-4. PubMed ID: 22924378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty.
    Niccolai LM; Russ C; Julian PJ; Hariri S; Sinard J; Meek JI; McBride V; Markowitz LE; Unger ER; Hadler JL; Sosa LE
    Cancer; 2013 Aug; 119(16):3052-8. PubMed ID: 23661284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus genotyping as a predictor of high-grade cervical dysplasia in women with mildly cytologic abnormalities: a two-year follow-up report.
    Huang LW; Lin YH; Pan HS; Seow KM; Lin CY
    Diagn Cytopathol; 2012 Aug; 40(8):673-7. PubMed ID: 21442773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of high-risk human papillomavirus (HR-HPV) infection among women with normal and abnormal cervical cytology in Myanmar.
    Mu-Mu-Shwe ; Harano T; Okada S; Aye-Aye-Win ; Khin-Saw-Aye ; Hlaing-Myat-Thu ; Mo-Mo-Win ; Khin-Khin-Oo ; Myo-Khin
    Acta Med Okayama; 2014; 68(2):79-87. PubMed ID: 24743783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and age-wise distribution of Human Papillomavirus type 16/18 infections among hospital screened women of a peri-urban area in West Bengal: Impact of socio-demographic factors.
    Bhattacharya A; Sen S; Mandal P; Sharma Saha S; Sarkar S; Pathak OP; Biswas L; Roy J; Banerjee R; Roy Chowdhury R; Pal M; Mukherjee A; Sengupta S
    Cancer Epidemiol; 2018 Jun; 54():31-37. PubMed ID: 29571035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program.
    Machalek DA; Roberts JM; Garland SM; Thurloe J; Richards A; Chambers I; Sivertsen T; Farnsworth A
    Med J Aust; 2019 Aug; 211(3):113-119. PubMed ID: 31168828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study.
    Park Y; Kim TJ; Hwang CS; Cho CH; Jeong DH; Seong SJ; Lee JK; Hur S; Kee MK; Seong J; Ki M
    J Gynecol Oncol; 2019 May; 30(3):e50. PubMed ID: 30887765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate biopsy of cervical cytology-negative and non-HPV-16/18 oncogenic types positive patients.
    Karaca İ; Öztürk M; Comba C; Demirayak G; Alay İ; Erdoğan VŞ; Hoşgören M; Yaşar L
    Diagn Cytopathol; 2018 Apr; 46(4):326-330. PubMed ID: 29460502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reliability of high-risk human papillomavirus detection by Aptima HPV assay in women with ASC-US cytology.
    Castle PE; Reid J; Dockter J; Getman D
    J Clin Virol; 2015 Aug; 69():52-5. PubMed ID: 26209379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.